Clinical Trials Directory

Trials / Conditions / Latent Tuberculosis Infection

Latent Tuberculosis Infection

37 registered clinical trials studyying Latent Tuberculosis Infection4 currently recruiting.

StatusTrialSponsorPhase
Not Yet RecruitingPrevalence of Latent Tuberculosis Infection Among Hemodialysis Patients
NCT07210970
Sohag University
Enrolling By InvitationEvaluation of a Novel Microbiological Diagnostic Test for Latent Mycobacterium Tuberculosis Infection
NCT06728930
Queen Mary University of London
RecruitingActive Screening of Latent Tuberculosis Infection in School Contacts of Active Tuberculosis Patients
NCT06033807
Huashan Hospital
RecruitingClinical Study of Recombinant Mycobacterium Tuberculosis Fusion Protein for 65-year-olds and Above
NCT05899179
Anhui Zhifei Longcom Biologic Pharmacy Co., Ltd.Phase 3
Active Not RecruitingClinical Trial of Mica
NCT05680415
Anhui Zhifei Longcom Biologic Pharmacy Co., Ltd.Phase 4
CompletedPhase IV Clinical Study of Recombinant Mycobacterium Tuberculosis Fusion Protein
NCT05746611
Anhui Zhifei Longcom Biologic Pharmacy Co., Ltd.Phase 4
TerminatedProspective Quality Improvement Project for High-Risk Diabetes Patients
NCT06472609
Taipei Medical University WanFang HospitalN/A
CompletedPerformance Evaluation of the VIDAS TB-IGRA Assay.
NCT04048018
BioMérieux
CompletedRisk of SDRs Under 3HP and 1HP Regimen for LTBI
NCT04094012
National Taiwan University HospitalPhase 3
CompletedNurse-Led Community Health Worker Adherence Model in 3HP Delivery Among Homeless Adults at Risk for TB Infecti
NCT03702049
University of California, IrvineN/A
Active Not RecruitingLatent Tuberculosis in Type 2 Diabetes
NCT06874725
Taichung Veterans General HospitalPhase 4
UnknownAdverse Drug Reactions to Anti-TB Drugs in the Treatment of Latent Tuberculosis Infection
NCT03312647
Hanyang University
CompletedEnhancing the Public Health Impact of Latent Tuberculosis (TB) Infection Diagnosis and Treatment
NCT02810678
McGill UniversityN/A
CompletedVDOT for Monitoring Adherence to LTBI Treatment
NCT02641106
University of California, San DiegoN/A
TerminatedImmune Responses to Mycobacterium Tuberculosis (Mtb) in People With Latent Tuberculosis Infection With or With
NCT02225158
National Institute of Allergy and Infectious Diseases (NIAID)
UnknownToward a Safe and Reachable Preventive Therapy for LTBI: a Multicenter Randomized Controlled Study in Taiwan
NCT02208427
National Taiwan University HospitalPhase 3
CompletedProspective Comparison of the Tuberculin Skin Test and Interferon-Gamma Release Assays in Diagnosing Infection
NCT01622140
Centers for Disease Control and Prevention
CompletedStudy 33: Adherence to Latent Tuberculosis Infection Treatment 3HP SAT Versus 3HP DOT
NCT01582711
Centers for Disease Control and PreventionPhase 3
UnknownTB mHealth Study - Use of Cell Phones to Improve Compliance in Patients on LTBI Treatment
NCT01549457
University of British ColumbiaEARLY_Phase 1
Terminated"Efficacy and Safety of Levofloxacin vs Isoniazid in Latent Tuberculosis Infection in Liver Transplant Patient
NCT01761201
Fundación Pública Andaluza para la gestión de la Investigación en SevillaPhase 3
CompletedRifampin Versus Isoniazid for the Treatment of Latent Tuberculosis Infection in Children (P4v9)
NCT00170209
McGill UniversityPhase 3
UnknownComparing Two Preventive Regimens for Latent Tuberculosis Infection (LTBI)
NCT01398618
National Taiwan University HospitalPhase 3
CompletedQuantiFERON®-TB Gold In-Tube for the Diagnosis of Tuberculosis Infection in Contact Tracing Study.
NCT01223534
Hospital Universitari de BellvitgePhase 4
CompletedClinical Trial to Investigate the Safety, Tolerability, and Immunogenicity of the Novel Antituberculous Vaccin
NCT01136161
Archivel Farma S.L.Phase 2
CompletedInterferon Gamma Release Assays (IGRA) Testing Versus Tuberculin Skin Test in Renal Transplant Recipients
NCT01608685
Ligue Pulmonaire Genevoise
CompletedRandomized Clinical Trial Comparing 4RIF vs. 9INH for LTBI Treatment-effectiveness
NCT00931736
McGill UniversityPhase 3
WithdrawnVitamin A Supplementation for Modulation of Mycobacterium Tuberculosis Immune Responses in Latent Tuberculosis
NCT00558480
Medical Research Council Unit, The GambiaN/A
UnknownDemonstration of the Dynamic Hypothesis of Latent Tuberculosis Infection
NCT00905970
Germans Trias i Pujol Hospital
CompletedScreening for Latent Tuberculosis Infection (LTBI) in US Army Recruits
NCT00804713
Henry M. Jackson Foundation for the Advancement of Military MedicineN/A
CompletedMedical and Economical Impact of IGRAs Diagnosis of Latent Tuberculosis in HIV-infected Patients
NCT00805272
Assistance Publique - Hôpitaux de ParisN/A
UnknownImpact of HIV Infection on Latent Tuberculosis (TB) Among Patients With HIV-TB Co-infection
NCT00692809
Ministry of Science and Technology, India
CompletedDiagnosis of Tuberculosis Infection in HIV Co-infected Children
NCT00541294
Case Western Reserve University
CompletedDiagnosis of Tuberculosis Infection in Health Care Workers Using Ex-vivo Interferon-gamma Assay
NCT01007396
Samsung Medical CenterN/A
CompletedIsoniazid Plus Antiretroviral Therapy to Prevent Tuberculosis in HIV-infected Persons
NCT00463086
University of Cape TownN/A
UnknownScreening for Latent Tuberculosis in Healthcare Workers With Quantiferon-Gold Assay: A Cost-Effectiveness Anal
NCT00449345
Assuta Hospital Systems
CompletedClinical Trial to Study 4 Different Doses of the Vaccine RUTI in Healthy Volunteers
NCT00546273
Germans Trias i Pujol HospitalPhase 1
CompletedUse of a Gamma-IFN Assay in Contact Tracing for Tuberculosis in a Low-Incidence, High Immigration Area
NCT00557765
University Hospital, Geneva